Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03388632
Brief Title: Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

First Submitted : December 30, 2017
First Submitted that Met QC Criteria : January 2, 2018
First Posted : January 3, 2018

Last Update Submitted that Met QC Criteria : April 17, 2019
Last Update Posted : April 18, 2019